Holstein heifers were used to study effects of exogenous administration of
oxytocin on luteal function and ovarian follicular development. Twelve heif
ers were monitored for 1 estrous cycle to confirm normal ovarian function.
At the subsequent estrus, these animals were randomly assigned to 1 of 3 tr
eatments: saline control, (Group 1, n = 4), oxytocin (Group 2, n = 4) and s
aline pregnant (Group 3, n = 4). Group 2 received continuous infusion of ox
ytocin (1.9 mg/d) from Days 14 to 26 after estrus, while Groups 1 and 3 rec
eived saline infusion during the same period. Group 3 were artificially ins
eminated at estrus. Daily blood samples were collected for oxytocin and pro
gesterone assay. Ovarian follicles and corpus luteum (CL) development were
monitored daily by transrectal ultrasonography until Day 32 after estrus. P
lasma progesterone (P-4) concentrations prior to initiation of infusion wer
e 7.6 +/- 1.3 ng/mL on Day 14. They then decreased to <1 ng/mL on Day 19 fo
r Group 1 and on Day 28 for Group 2. The interestrous interval was longer (
P < 0.05) for heifers that received oxytocin infusion. During the infusion
period Pq concentrations were not different (P > 0.05) between Group 2 and
3 but declined gradually from Day 20 in Group 2 despite the presence of hig
h plasma oxytocin concentrations. Control heifers had 2 waves of follicular
growth, with the second dominant follicle ovulating. Three of the 4 oxytoc
in-infused animals had an additional wave, with the third dominant follicle
ovulating. Oxytocin infusion had no effect on size of the ovulating follic
le (P > 0.05) and the number of Class 1 follicles (3 to 5 mm, P > 0.1). Dif
ferences in the number of Class 2 follicles (6 to 9 mm) among treatments on
Days 15 to 22 after estrus were not detected (P > 0.1) except on Days 23 t
o 26, when Group 2 had fewer follicles than Group 3 (P < 0.05).The results
show that continuous infusion of oxytocin during normal luteolysis delays l
uteal regression without inhibiting follicular development. (C) 2000 by Els
evier Science Inc.